List of redirects

Showing below up to 50 results in range #52,951 to #53,000.

52951. The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS IIb Guidelines → ST elevation myocardial infarction secondary prevention
52952. The Living Guidelines: STEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS I Guidelines → ST elevation myocardial infarction secondary prevention
52953. The Living Guidelines: STEMI Reperfusion View the Current CLASS I Guidelines → ST elevation myocardial infarction reperfusion therapy
52954. The Living Guidelines: STEMI Thienopyridines View the Current CLASS IIa Guidelines → ST elevation myocardial infarction thienopyridine therapy
52955. The Living Guidelines: STEMI Thienopyridines View the Current CLASS I Guidelines → ST elevation myocardial infarction thienopyridine therapy
52956. The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. View the Current CLASS IIa Guidelines → Congestive heart failure clinical assessment
52957. The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. View the Current CLASS IIb Guidelines → Congestive heart failure clinical assessment
52958. The Living Guidelines: Serial Clinical Assessment of Patients Presenting with Heart Failure. View the Current CLASS I Guidelines → Congestive heart failure clinical assessment
52959. The Living Guidelines: Treatment of Special Populations. View the Current CLASS IIa Guidelines → Congestive heart failure treatment of special populations
52960. The Living Guidelines: Treatment of Special Populations. View the Current CLASS I Guidelines → Congestive heart failure treatment of special populations
52961. The Living Guidelines: UA/NSTEMI Anticoagulant Therapy View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
52962. The Living Guidelines: UA/NSTEMI Anticoagulant Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
52963. The Living Guidelines: UA/NSTEMI Antiplatelet Therapy View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction antiplatelet therapy#ACC / AHA Guidelines (DO NOT EDIT)
52964. The Living Guidelines: UA/NSTEMI Antiplatelet Therapy View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction antiplatelet therapy#ACC / AHA Guidelines (DO NOT EDIT)
52965. The Living Guidelines: UA/NSTEMI Antiplatelet Therapy View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction antiplatelet therapy#ACC / AHA Guidelines (DO NOT EDIT)
52966. The Living Guidelines: UA/NSTEMI Antiplatelet Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction antiplatelet therapy#ACC / AHA Guidelines (DO NOT EDIT)
52967. The Living Guidelines: UA/NSTEMI Recomendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction additional management considerations for antiplatelet and anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
52968. The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction additional management considerations for antiplatelet and anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
52969. The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction additional management considerations for antiplatelet and anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
52970. The Living Guidelines: UA/NSTEMI Recommendations for Additional Management Considerations for Antiplatelet and Anticoagulant Therapy View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction additional management considerations for antiplatelet and anticoagulant therapy#ACC / AHA Guidelines (DO NOT EDIT)
52971. The Living Guidelines: UA/NSTEMI Recommendations for Anti Ischemic Therapy View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction initial therapy
52972. The Living Guidelines: UA/NSTEMI Recommendations for Anti Ischemic Therapy View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction initial therapy
52973. The Living Guidelines: UA/NSTEMI Recommendations for Anti Ischemic Therapy View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction initial therapy
52974. The Living Guidelines: UA/NSTEMI Recommendations for Anti Ischemic Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction initial therapy
52975. The Living Guidelines: UA/NSTEMI Recommendations for Antioxidant Vitamins and Folic Acid Use View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
52976. The Living Guidelines: UA/NSTEMI Recommendations for Beta Blockers Therapy View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
52977. The Living Guidelines: UA/NSTEMI Recommendations for Beta Blockers Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
52978. The Living Guidelines: UA/NSTEMI Recommendations for Blood Pressure Control View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
52979. The Living Guidelines: UA/NSTEMI Recommendations for CABG View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction recommendations for CABG#ACC / AHA Guidelines (DO NOT EDIT)
52980. The Living Guidelines: UA/NSTEMI Recommendations for CABG View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction recommendations for CABG#ACC / AHA Guidelines (DO NOT EDIT)
52981. The Living Guidelines: UA/NSTEMI Recommendations for CABG View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction recommendations for CABG#ACC / AHA Guidelines (DO NOT EDIT)
52982. The Living Guidelines: UA/NSTEMI Recommendations for CABG View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction recommendations for CABG#ACC / AHA Guidelines (DO NOT EDIT)
52983. The Living Guidelines: UA/NSTEMI Recommendations for Calcium Channel Blockers Therapy View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
52984. The Living Guidelines: UA/NSTEMI Recommendations for Cardiac Rehabilitation View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction cardiac rehabilitation#ACC / AHA Guidelines (DO NOT EDIT)
52985. The Living Guidelines: UA/NSTEMI Recommendations for Depression View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
52986. The Living Guidelines: UA/NSTEMI Recommendations for Diabetes Mellitus Management View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
52987. The Living Guidelines: UA/NSTEMI Recommendations for Early Risk Stratification View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction risk stratification and prognosis
52988. The Living Guidelines: UA/NSTEMI Recommendations for Early Risk Stratification View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction risk stratification and prognosis
52989. The Living Guidelines: UA/NSTEMI Recommendations for Early Risk Stratification View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction risk stratification and prognosis
52990. The Living Guidelines: UA/NSTEMI Recommendations for Early Risk Stratification View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction risk stratification and prognosis
52991. The Living Guidelines: UA/NSTEMI Recommendations for Hormone Therapy View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
52992. The Living Guidelines: UA/NSTEMI Recommendations for Identification of Patients at Risk of UA/NSTEMI View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction diagnosis
52993. The Living Guidelines: UA/NSTEMI Recommendations for Immediate Management View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction immediate management#ACC / AHA Guidelines (DO NOT EDIT)
52994. The Living Guidelines: UA/NSTEMI Recommendations for Immediate Management View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction immediate management#ACC / AHA Guidelines (DO NOT EDIT)
52995. The Living Guidelines: UA/NSTEMI Recommendations for Influenza Vaccination View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
52996. The Living Guidelines: UA/NSTEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS IIa Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
52997. The Living Guidelines: UA/NSTEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
52998. The Living Guidelines: UA/NSTEMI Recommendations for Inhibition of the Renin-Angiotensin-Aldosterone System View the Current CLASS I Guidelines → Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention
52999. The Living Guidelines: UA/NSTEMI Recommendations for Initial Conservative vs Initial Invasive Strategies View the Current CLASS III Guidelines → Unstable angina / non ST elevation myocardial infarction initial conservative versus initial invasive strategies#ACC / AHA Guidelines (DO NOT EDIT)
53000. The Living Guidelines: UA/NSTEMI Recommendations for Initial Conservative vs Initial Invasive Strategies View the Current CLASS IIb Guidelines → Unstable angina / non ST elevation myocardial infarction initial conservative versus initial invasive strategies#ACC / AHA Guidelines (DO NOT EDIT)